WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

ATC/DDD alterations 2018

ATC alterations

Previous ATC codeATC level name New ATC code
A01AD02 1)benzydamine R02AX03
H01BA06argipressinH01BA01 2)
J01DD54 3)ceftriaxone, combinationsJ01DD63
J05AB04ribavirinJ05AP01
J05AE11telaprevirJ05AP02
J05AE12boceprevirJ05AP03
J05AE13faldaprevirJ05AP04
J05AE14simeprevir J05AP05
J05AE15asunaprevirJ05AP06
J05AX14daclatasvirJ05AP07
J05AX15sofosbuvirJ05AP08
J05AX16dasabuvirJ05AP09
J05AX65sofosbuvir and ledipasvirJ05AP51
J05AX66dasabuvir, ombitasvir, paritaprevir and ritonavir J05AP52
J05AX67ombitasvir, paritaprevir and ritonavir J05AP53
J05AX68elbasvir and grazoprevir J05AP54
J05AX69sofosbuvir and velpatasvirJ05AP55
1) Split of code. Alteration of ATC code applies only for benzydamine lozenges
2) New ATC level name vasopressin (argipressin)
3) Split of code. Combinations of ceftriaxone and other substances remain in J01DD54 while combinations of ceftriaxone and beta-lactamase inhibitors are moved to J01DD63 ceftriaxone and beta-lactamase inhibitor

Other ATC alterations

ATC codePrevious ATC level name New ATC level name or new ATC level
R03ALAdrenergics in combinations with anticholinergicsAdrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
J01CR02amoxicillin and enzyme inhibitoramoxicillin and beta-lactamase inhibitor
J01CR01ampicillin and enzyme inhibitorampicillin and beta-lactamase inhibitor
J05APAntivirals for treatment of HCV infections
A05AABile acid preparationsBile acids and derivatives
J01DD62cefoperazone, combinationscefoperazone and beta-lactamase inhibitor
J01DD51cefotaxime, combinationscefotaxime and beta-lactamase inhibitor
J01DD52ceftazidime, combinationsceftazidime and beta-lactamase inhibitor
J01DI54ceftolozane and enzyme inhibitorceftolozane and beta-lactamase inhibitor
B02BD08eptacog alfacoagulation factor VIIa
L01XC05gemtuzumabgemtuzumab ozogamicin
J01DH51imipenem and enzyme inhibitorimipenem and cilastatin
J01CR05piperacillin and enzyme inhibitorpiperacillin and beta-lactamase inhibitor
J01CR03ticarcillin and enzyme inhibitorticarcillin and beta-lactamase inhibitor

DDD alterations

ATC codeATC level name Previous DDD New DDD
A03AB02glycopyrronium bromide3 mg P0.3 mg P
L04AC01daclizumab0.35 g P5 mg P

Last updated: 2017-11-29